Product
Placebo Comparator
Aliases
Placebo, Placebo Comparator 0.25 mg/kg/day
15 clinical trials
17 indications
Indication
Healthy VolunteerIndication
Age-related macular degenerationIndication
AchondroplasiaIndication
Primary DysmenorrheaIndication
Amyotrophic lateral sclerosisIndication
Type 1 Diabetes MellitusIndication
Bacterial InfectionsIndication
DengueIndication
InfluenzaIndication
Dry Eye SyndromeIndication
COVID-19Indication
Facioscapulohumeral Muscular DystrophyIndication
Long COVIDIndication
Long Covid-19Indication
frailtyIndication
EsmololIndication
Myocardial InjuryClinical trial
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Single-Center, Human Tick Kill Proof-of-Concept Study Evaluating the Safety, Tolerability, and Whole Blood Concentration of TP-05 (Lotilaner) in Healthy VolunteersStatus: Active (not recruiting), Estimated PCD: 2024-06-27
Clinical trial
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Infigratinib in Children 3 to <18 Years of Age With Achondroplasia: PROPEL 3Status: , Estimated PCD: 2025-12-31
Clinical trial
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).Status: Recruiting, Estimated PCD: 2027-07-15
Clinical trial
A National, Multicenter, Randomized, Double-blind, Phase III, Crossover Clinical Trial to Assess the Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.Status: Not yet recruiting, Estimated PCD: 2027-02-01
Clinical trial
A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral SclerosisStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Oral QPX7831 in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of 0.25% Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-10-11
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Multiple Ascending Doses Study Following Intravenous Administration in Healthy Chinese Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of HNC042Status: Completed, Estimated PCD: 2020-11-13
Clinical trial
A Phase 1, Double-blind, Randomized, Placebo-controlled Study to Assess the Antiviral Activity and Safety of AT-752 in a Dengue Human Challenge ModelStatus: Terminated, Estimated PCD: 2023-03-16
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess the Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Multiple Doses of REMD-477 in Subjects With Type 1 Diabetes MellitusStatus: Completed, Estimated PCD: 2021-03-05
Clinical trial
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-03-25
Clinical trial
A Bicentric, Randomized, Double Blind, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1Status: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Status: , Estimated PCD: 2025-07-01
Clinical trial
Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2026-11-30